Sidhu Someit
Known title: Chief Executive OfficerCIK: 0001870329
Sidhu Someit's purchase track record
Sidhu Someit has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/22/2024 | ZURA | $3.72M | +7.8% | +45.9% | +16.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| JATT | ▼ Sell | Other | 225,000 | $0 | 6/6/2026 | View on chart |
| JATT | ▲ Buy | Open Market | 300,000 | — | 4/20/2026 | View on chart |
| ZURA | ▼ Sell | Open Market | 51,728 | $200K | 9/4/2024 | View on chart |
| ZURA | ▲ Buy | Open Market | 1,186,901 | $3.7M | 4/22/2024 | View on chart |
| ZURA | ▼ Sell | Other | 2,337,630 | — | 3/20/2023 | View on chart |
| ZURA | ▼ Sell | Other | 2,337,630 | — | 2/10/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Zura Bio Named Top Pick by Guggenheim Amid Recent Price Gains
Zura Bio was highlighted as a top pick by Guggenheim, contributing to its recent upward movement alongside other stocks. The company's share price has risen, though it remains well below the average analyst target of $18.00. Current trading levels sit near the lower end of its 52-week range, reflecting a significant gap between current market price and long-term valuation estimates.
Zura Bio Named Top Pick by Guggenheim Amid Recent Price Gains. Zura Bio was highlighted as a top pick by Guggenheim, contributing to its recent upward movement alongside other stocks. The company's share price has risen, though it remains well below the average analyst target of $18.00. Current trading levels sit near the lower end of its 52-week range, reflecting a significant gap between current market price and long-term valuation estimates.